Application 201803

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ADVILIBUPROFEN SODIUMTABLET;ORALEQ 200MG BASEYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N201803-001ADVILIBUPROFEN SODIUMEQ 200MG BASETABLET / ORALRLD, RS2012-06-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1231067a03dcf5…
2025-08-23 18:47 UTC2025-08N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-126a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-122680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-125bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-121e350fbaab3a…
2024-05-31 18:47 UTC2024-05N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-128072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-125c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-125d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-124b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-1287673890dc5c…
2021-03-12 10:30 UTC2021-03N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-125aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-128869cabd3fbd…
2020-11-12 02:37 UTC2020-11N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12c0c555d07b60…
2019-12-14 00:12 UTC2019-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-123f01610625f2…
2019-09-15 20:21 UTC2019-09N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12b00525d2431f…
2019-07-19 19:46 UTC2019-07N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-126a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-121c564ffb4f44…
2023-12-20 04:57 UTC2023-12N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-129b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-123f0d92c62455…
2023-05-13 08:27 UTC2023-05N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12053a50430f4f…
2023-01-26 05:58 UTC2023-01N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-123bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-123a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N201803-001ADVILEQ 200MG BASETABLET / ORALRLD, RS2012-06-12e64feba35796…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AdvilIBUPROFEN SODIUMHaleon US Holdings LLC5be198b8-396e-4b44-8819-e2e3b5d2ad0e2025-10-03WarningsExact identifier
application applno (NDA): 201803
application number: NDA201803
ndc (product): 0573-0133
ndc (product): 0573-0134
Advil Menstrual PainIBUPROFEN SODIUMHaleon US Holdings LLCae1625f4-ef32-4d4f-bf54-c44085843e412024-01-31WarningsExact identifier
application applno (NDA): 201803
application number: NDA201803
ndc (product): 0573-0230

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 13 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0573-0133Advilibuprofen sodiumGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-0133Advilibuprofen sodiumWyeth Consumer Healthcare LLCNDACurrent
0573-0133Advilibuprofen sodiumGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-0133Advilibuprofen sodiumWyeth Consumer Healthcare LLCNDACurrent
0573-0133Advilibuprofen sodiumGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-0134Advilibuprofen sodiumGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-0134Advilibuprofen sodiumWyeth Consumer Healthcare LLCNDACurrent
0573-0134Advilibuprofen sodiumGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-0134Advilibuprofen sodiumWyeth Consumer Healthcare LLCNDACurrent
0573-0134Advilibuprofen sodiumGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-0230Advil Menstrual Painibuprofen sodiumGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-0230Advil Menstrual Painibuprofen sodiumPfizer Consumer HealthcareNDACurrent
0573-0230Advil Menstrual Painibuprofen sodiumGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
70131SUPPL2022-02-09
70130SUPPL2022-02-09
54412SUPPL2018-06-01
54404SUPPL2018-06-01
53788SUPPL2018-04-23
53691SUPPL2018-04-16
49542SUPPL2017-08-25
49534SUPPL2017-08-24
48717SUPPL2017-06-14
48710SUPPL2017-06-13
40087SUPPL2016-06-10
9930SUPPL2016-06-07
44837ORIG2012-11-29
22861ORIG2012-11-29
40086ORIG2012-08-30
32138ORIG2012-06-14